Preparation and evaluation of pranoprofen gel for percutaneous administration

Drug Development and Industrial Pharmacy

Volumn 33, Issue 1, 2007, Pages 19-26

  Choi, Jun Shik ^a   Shin, Sang Chul ^b  

^a Chosun University   (South Korea)

^b Chonnam National University   (South Korea)

Author keywords

Anti inflammatory effects; Gender; Penetration enhancer; Pranoprofen gels; Swelling

Indexed keywords

CELLULOSE; FATTY ACID; HYDROXYPROPYLMETHYLCELLULOSE; NONIONIC SURFACTANT; NONSTEROID ANTIINFLAMMATORY AGENT; OCTANOIC ACID; PENETRATION ENHANCING AGENT; POLIDOCANOL; POLOXAMER; POLYOXYETHYLENE OLEYL ETHER; POLYOXYETHYLENE STEARYL ETHER; PRANOPROFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG FORMULATION; DRUG METABOLISM; DRUG PENETRATION; DRUG RELEASE; DRUG SCREENING; DRUG SYNTHESIS; FEMALE; FIRST PASS EFFECT; GEL; MALE; NONHUMAN; PAW EDEMA; RAT; TEMPERATURE;

ADMINISTRATION, CUTANEOUS; AGE FACTORS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BENZOPYRANS; GELS; MALE; PROPIONIC ACIDS; RATS; RATS, SPRAGUE-DAWLEY; SEX CHARACTERISTICS; SOLUBILITY; TEMPERATURE;

EID: 33845929290     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040600975071     Document Type: Article

References (17)

1. Angust, B. J., & Rogers, N. J. (1989). Comparison of the effects of various transmucosal absorption promoters on buccal insulin delivery. Int. J. Pharm., 53, 227-235.
2. Chen-Chow, P., & Frank, S. G. (1981). In vitro release of lidocaine from Pluronic F-127 gels. Int. J. Pharm., 8, 89-99.
3. Durrhein, H., Flynn, G. l., Higuchi, W. I., & Behl, C. R. (1980). Permeation of hairless mouse skin: Experimental methods and comparison with human epidermis permeation by alkanols. J. Pharm. Sci., 69, 781.
4. Gennaro, A. R. (1995). Remington: The Science and Practice of Pharmacy. (19th ed.). Easton. PA: Mack Publishing Company,: pp.1207-1218.
5. Ishida, M., Machida, Y., Nambu, N., & Nagai. T. (1981).New mucosal dosage form of insulin. Chem. Pharm. Bull., 209, 810-816.
6. Larrucea, E., Arellano, A., Santoya, S., & Ygartua, P. (2001). Interaction of tenoxicam with cyclodextrin and its influence on the in vitro percutaneous penetration of the drug. Drug Dev. Ind. Pharm., 27, 251-260.
7. Levy L. (1969). Carrageenan paw edema in the mouse. Life Sci., 8, 601-606.
8. Miyazaki, S., Takeuchi, S., Yokouchi, C., & Takada, M. (1984). Pluronic F-127 gels as a vehicle for topical administration of anticancer agents. Chem. Pharm. Bull., 32, 4205-4208.
9. Mohamed, F. A. (2001). Topical permeation characteristics of diclofenac sodium from Na-CMC gels in comparison with conventional gel formulations. Drug Dev. Ind. Pharm., 27, 1083-1087.
10. Rhee, G. J., Woo, J. S., Hwang, S. J., Lee, Y. W., & Lee, C. H. (1999). Topical Oleo-hydrogel preparation of kototifen with enhanced skin permeability. Drug Dev. Ind. Pharm., 25, 717-726.
11. Schmolka, M. (1972).Artificial skin I. preparation and properties of pluronic F-127 gels for treatment of burns. J. Biomed. Mater. Res., 6, 571-582.
12. Shin, S. C., Cho, C. W., & Choi, H. K. (1999). Permeation of piroxicam from the poloxamer gels. Drug Dev. Ind. Pharm., 25, 273-279.
13. Shin, S. C., Cho, C. W., & Oh, I. J. (2000). Enhanced efficacy by percutaneous absorption of piroxicam from the poloxamer gels in rats. Int. J. Pharm., 193, 213-218.
14. Shin, S. C., & Kim, J. Y. (2000). Enhanced permeation of triamcinolone acetonide through the buccal mucosa. Eur. J. Pharm. Biopharm., 50, 217-220.
15. Shin, S. C., Cho, C. W., & Oh, I. J. (2001). Effects of non-ionic surfactants as permeation enhancers towards piroxicam from the poloxamer gel through rat skins. Int. J. Pharm., 222, 199-203.
16. Shin, S. C., Kim, H. J., Oh, I. J., Cho, C. W., & Yang, K. H. (2005). Development of tretinoin gels for enhanced transdermal delivery. Eur. J. Pharm. Biopharm., 60, 67-71.
17. Sinha, V. A., & Kaur, M. (2000). Permeation enhancers for transdermal drug delivery. Drug Dev. Ind. Pharm., 26, 1131-1140.